Table 3.
Unadjusted and mutually adjusted rate ratios (RR) for any recurrence by baseline characteristics following complete eradication of intestinal metaplasia (CE-IM) among patients with at least one surveillance endoscopy after achieving CE-IM.
| Characteristic | Recurrence - N (%) | No Recurrence - N (%) | Unadjusted RR (95% CL) | Adjusted RR (95% CL) |
|---|---|---|---|---|
| Age (years) - 25 to 60 | 8 (15.4) | 26 (16.1) | 0.89 (0.39 – 1.82) | 1.03 (0.43 – 2.20) |
| - 61 to 80 | 36 (69.2) | 109 (67.7) | Ref. | Ref. |
| - 81 to 101 | 8 (15.4) | 26 (16.1) | 0.90 (0.39 – 1.84) | 1.09 (0.45 – 2.38) |
| BMI (mg/kg2) - Normal (18.5 – 24.9) | 9 (17.3) | 20 (12.3) | Ref. | Ref. |
| - Overweight (25.0 – 29.9) | 19 (36.5) | 77 (47.5) | 0.57 (0.27 – 1.33) | 0.48 (0.21 – 1.16) |
| - Obesity (>=30) | 24 (46.2) | 65 (40.1) | 0.66 (0.32 – 1.50) | 0.65 (0.30 – 1.52) |
| Female | 13 (25.0) | 55 (33.5) | Ref. | Ref. |
| Male | 39 (75.0) | 109 (66.5) | 1.17 (0.64 – 2.29) | 1.23 (0.69 – 2.52) |
| Prague M length (cm) - 0 to 3 | 13 (25.0) | 74 (46.3) | Ref. | Ref. |
| - 4 or greater | 39 (75.0) | 86 (53.8) | 2.33 (1.28 – 4.55) | 2.08 (1.09 – 4.18) |
| Prague C length (cm) - 0 to 3 | 41 (78.8) | 151 (92.1) | Ref. | Ref. |
| - 4 or greater | 11 (21.2) | 13 (7.9) | 2.93 (1.43 – 5.49) | 2.55 (1.18 – 5.25) |
| Baseline grade – Low-grade dysplasia | 19 (36.5) | 56 (34.1) | Ref. | Ref. |
| - High-grade dysplasia | 31 (59.6) | 95 (59.9) | 1.15 (0.65 – 2.06) | 1.36 (0.75 – 2.51) |
| - Intramucosal adenocarcinoma | 2 (3.8) | 13 (7.9) | 0.51 (0.08 – 1.75) | 0.73 (0.11 – 2.76) |
BMI, body mass index.